Home > Insider Trading > Filing (0001437749-24-035887)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1855175	Contineum Therapeutics Inc.	CTNM	Pharmaceutical Preparations (2834)	271467257

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1861550	S. Daniel Lorrain	3565 General Atomics Court, Suite 200 San Diego CA 92121	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2024-11-18	6,091	$16.37	169,671	No	4	S	Direct
Class A Common Stock	Disposition	2024-11-18	99	$17.05	169,572	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Common Stock	3,898	Indirect	By Spouse

Footnotes

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 19, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.03 to $17.02, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Includes 325 shares purchased through Issuer's Employee Stock Purchase Plan.